Carcinoembryonic antigen in hepatocellular cancer. by Macnab, G. M. et al.
Br. J. Cancer (1978) 38, 51
CARCINOEMBRYONIC ANTIGEN IN HEPATOCELLULAR CANCER
AL. M. IACNAB*, J. M. URBANOMICZ* AND M. C. KEWt
Fromin *the School of l'athology of the South, African Institute for 3ledical Research and the University
of the IWitwatersrand, and tthe Departmtent of Jledicine, Johannesburg Hospital and University
of the IVitwiatersrand and the South African Primary Liver Cancer Research Unit,
Johaln esburg, South Africa
Received 17 February 1978 Acceptedl 4 April 1978
Summary.-Serum carcinoembryonic antigen (CEA) concentrations were found to
be raised in 28 of 72 black patients (390/) with hepatocellular cancer (HCC). The
degree of elevation was slight or moderate, except in 3 patients in whom values
>20 ng/ml were recorded. No significant correlation could be demonstrated in indi-
vidual patients between the serum CEA concentration and various tests of liver
function. The mean CEA value in the patients with cirrhosis in the non-tumorous
liver was slightly higher than that in those without cirrhosis, but the difference did
not reach statistical significance. There was no correlation between serum CEA and
a-foetoprotein (AFP) levels.
Carcinoembryonic antigen (CEA) is
frequently found in high concentration in
the serum of patients with digestive-tract
malignancies, particular carcinoma of
the colon, and to a lesser extent in those
with breast or bronchogenic carcinomas
(Booth et al., 1973). The glycoprotein is
thought to be produced and secreted by
the tumour tissue. Moderately raised
values have also been recorded in various
forms of benign liver disease, particularly
that due to alcohol (Moore et al., 1972).
CEA levels in hepatocellular cancer (HCC)
have not been studied in detail, although
raised concentrations were reported in
8/12 patients by Lo Gerfo et al., (1971)
and in 10/1 6 patients by Khoo et al.,
(1973). Such an investigation would have
to take into account both the liver func-
tion of the patients, since hepatic dys-
function may cause CEA values to be
slightly or moderately raised (Lowenstein
and Zamcheck, 1977), and the presence or
absence of cirrhosis in the non-tumorous
liver. The latter is frequently present in
HCC patients, and it is one of the forms
of benign liver disease which may be
associated with raised serum CEA values
(Lowenstein and Zamcheck, 1977).
Synthesis and secretion of another car-
cino-foetal protein, a-foetoprotein (AFP),
by HCC is well known (Kew, 1974) and
more recently, this tumour has also been
shown to produce an acidic isoferritin
(Niitsu et al., 1975; Kew et al., 1978).
We have demonstrated a negative correla-
tion between the serum concentrations
of these two proteins (Kew et al., 1978)
suggesting a reciprocal relationship in
their secretion. The relationship between
CEA and AFP in HCC has not yet been
investigated.
The purpose of the present study was
to measure CEA concentrations in the
serum of patients with HCC, and to
determine whether these were related to
tests of liver function, to the presence or
absence of cirrhosis in the non-tumorous
liver, and to serum AFP levels.
PATIENTS AND METHODS
Seventy-two southern African blacks witl
histologically proven HCC were studied.
There were 64 men and 8 women. Their ages
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ranged from 21-63 years with a mean age of
41-4. Serum was collected from the patients
before treatment was started. One hundred
apparently healthy blood donors (80 non-
smokers and 20 smokers) served as controls.
Samples ofblood (10 ml) were drawn by vene-
puncture and placed in sterile vacutainers
containing EDTA and potassium sorbate.
The blood was mixed thoroughly by gentle
inversion. The serum was separated within
2 h and stored at -20°C until the assay was
performed. CEAconcentrationsweremeasured
using the zirconyl-phosphate-gel method
described by Lo Gerfo et al. (1971) (Hoffman-
Roche kits were used). In 52 patients, serum
bilirubin and albumin concentrations, gluta-
mic oxaloacetic transaminase (GOT) and
glutamic pyruvic transaminase (GPT) and
alkaline phosphatase activities, and the
prothrombin index were measured using
standard laboratory methods. AFP concen-
trations were measured by radioimmunoassay
(Ruoslahti and Seppala, 1971) in all patients.
In 24 subjects the presence or absence of
cirrhosis was established at necropsy. In an
attempt to relate the serum CEA concentra-
tion to the extent of spread of the tumour,
plain x-ray films of the chest of 32 patients
were examined for the presence of pulmonary
metastases.
Parametric statistical methods (Pearson's
correlation coefficient) were used for the
correlations between CEA values and the
other indices assessed.
RESULTS
Serum CEA concentrations in the 80
non-smoking control subjects ranged from
0*0-25 ng/ml, while in the 20 controls
who smoked, values of up to 29 ng/ml
were recorded. Serum CEA concentrations
in the HCC patients ranged from 0-0-115
ng/ml with a mean of 5-3 ng/ml and s.e.
1-7 ng/ml. Twenty-eight patients (38.9%)
had CEA values > 2-5 ng/ml. In 26 of
these (36%) the values were > 3-0 ng/ml.
Three patients (40%) had concentrations
in the "cancer range" ( > 20 ng/ml). The
distribution of the individual values is
shown in Fig. 1.
There was no significant correlation in
individual patients between the serum
CEA concentration and serum bilirubin
6C
5s
4a
0%
30
20
ic la% _ _X _. _-
_[ ___
__
___.
__
_s _
_ __, _____
_e _mffl
24-5¢0 5¢1-104 10@E20@0 >20
SERUMC EA CONCENTRATION (ng/ml)
Fic. 1. The distribution of CEA values in 72
patients with hepatocellular cancer.
(r-0-0660, serum albumin (r- 0-1471)
GOT (r = 0.0340) GPT (r - 0.0326) or
alkaline phosphatase (r 041108) values;
P being > 0 05 in every case. There was
likewise no correlation between the serum
CEA and AFP values (r - 0.0444) (Fig.
2). Macronodular cirrhosis was present in
19/24 patients examined at necropsy.
When the serum CEA concentrations in
these patients were compared with those
in the 5 patients without cirrhosis, the
levels were higher in the former (means
± s.d. being 3-17 + 3-23 vs 1-94 ± 1-24)
but the difference did not reach statistical
significance (t- 0826, P > 0.1). The
serum CEA concentrations in the 12
patients with radiologically apparent pul-
monary metastases (3.93 ± 4-08 ng/ml;
mean ± s.d.) were not significantly differ-
ent from those of the 20 patients without
these metastases (8.0 + 25-3 ng/ml) (P >
0.1).
DISCUSSION
Forty percent of black patients with
HCC had serum CEA concentrations
> 2*5 ng/ml, which is the upper limit of
the normal range using the zirconyl-
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Fig. 2.- Relationship between serum CEA
aind: AFP concentrations in 72 patients with
hepatocellular cancer. No correlation was
found (r=0-0444, P>0-05).
phosphate-gel method. McCartney and
Hoffer (1974) have found that using
3 ng/ml as the dividing level between
normal and elevated concentrations they
can eliminate false-positive results whilst
not increasing the number of false-nega-
tive results. If the latter value was used,
to allow for the effect of cigarette smoking
on the CEA concentration and for those
otherwise normal individuals who have
values slightly above 2-5 ng/ml, 36% of
the HCC patients had elevated CEA levels.
However, only a small proportion of the
patients (40o) had levels in the 'cancer
range' of above 20 ng/ml. It follows that
estimation of serum CEA concentrations
is of little or no value in the diagnosis of
HCC.
Studies in experimental animals have
shown that CEA is rapidly removed from
the plasma by the liver and is then
excreted virtually unchanged into the
bile (Thomas and Hems, 1975). It appears
that asialo-carcinoembryonic antigen is
taken up directly by hepatocytes, presum-
ably due to recognition of terminal galac-
tose residues by the galactose receptor
present on the plasma membrane of the
hepatocyte (Ashwell and Morell, 1974).
However, native CEA is initially taken
up by Kupffer cells and then transferred
to the hepatocytes (Thomas et al., 1977).
CEA values are known to be mildly or
moderately raised in various forms of
benign liver disease (Moore et al., 1972;
Bullen et al., 1977), This may be due
either to failure of the hepatocytes to
take up, metabolize or excrete the small
amount of CEA normally present in the
serum, to release of the protein from
damaged liver cells, to production of CEA
during regeneration of hepatocytes, or to
shunting of blood from the gut into the
systemic circulation. Varying degrees of
liver dysfunction occur in patients with
HCC, due either to the effects of the
tumour itself or to the underlying macro-
nodular cirrhosis, and this might explain
the raised levels in most of our patients.
However, we could find no correlation
between the serum CEA concentrations in
individual patients and selected tests of
liver function or damage to hepatocytes.
CEA values in the patients with cirrhosis
in the nontumorous liver were somewhat
higher than those without, although the
number of patients without cirrhosis was
too small to allowfor meaningful statistical
evaluation.
The CEA values in patients with non-
alcoholic cirrhosis are only moderately
raised (Moore et al., 1972; Khoo et al.,
1973). It seems unlikely, therefore, that
cirrhosis can have accounted for the few
patients in our series with values > 10
ng/ml. It is in this group of patients, and
particularly in those with concentrations
above 20 ng/ml, that production of CEA
by the tumour itself, in much the same
way as occurs with colonic carcinomas,
seems likely. Proof of this mechanism
could be provided by demonstrating CEA
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in the tumour tissue using immunoper-
oxidase or immunofluorescence, or by
estimating the CEA content ofthe tumour
by radioimmunoassay, as has been done
with other tumours (Sharkey et al., 1977).
The carcino-foetal protein most often
produced by HCC is AFP. Positive tests
for AFP by immunodiffusion are present
in 78% of southern African blacks with
HCC (Kew, 1974) and with radioimmuno-
assay the concentrations are raised in
about 96% of the patients. The relation-
ship between CEA and AFP in patients
with HCC has not previously been re-
ported. In the present study no correlation
could be demonstrated between the two
carcino-foetal proteins. This is similar to
the finding in germ-cell neoplasms, which
also produce both AFP and CEA (Taler-
man et al., 1977).
The authors acknowledge with gratitude support
from the National Cancer Association of South
Africa.
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